Hemostasis/Coagulation Analyzers Market

Industry Outlook

The growing demand for coagulation or hemostasis analyzers is mainly driven by the consistently increasing population base suffering from lifestyle diseases and blood disorders. It is predicted that increasing awareness about inherited blood disorders and improving diagnosis rates will increase the pace of the hemostasis analyzer market. The rapidly developing healthcare infrastructure in the Asia Pacific and Latin America is driving significant demand for automated analyzers in these emerging markets.

The growing incidence of cardiac diseases and blood disorders is anticipated to catalyze the uptake of coagulation tests. It is an established fact that cardiovascular disease patients are at a higher risk of developing coagulation conditions causing ischemic stroke. Therefore, an increasing geriatric population and a substantially growing patient pool for cardiovascular diseases will build the market for hemostasis analyzers. Moreover, improving automation and the introduction of portable analyzers have further aided in increasing the adoption of these systems in ambulatory and emergency care settings. Additionally, the ease of operating these devices has also reduced the requirement for further skills in healthcare settings, further increasing their adoption in remote settings and clinics.

Market Synopsis

Growing hematological disease incidence and awareness will drive demand for routine coagulation tests.

Modern coagulation laboratories perform a variety of tests that allow for an accurate and thorough diagnosis. Some tests are also used for monitoring the effects of anticoagulant therapy. Hemostasis and coagulation analyses are classified into diagnostic hemostasis assays and routine coagulation tests based on this. Routine coagulation tests are mostly done in clinical labs, whereas diagnostic hemostasis assay tests are usually done in specialized labs for specific diagnosis and characterization of defects.PT and APTT test types in routine coagulation tests occupy the largest share of the global market. The APTT test mainly detects coagulation inhibitors, monitors heparin therapy, and detects inherited abnormalities.

Large purchase volume of consumables to spur the market’s growth.

Currently, analyzers hold the largest share in the global hemostasis and coagulation analyzer market and will further advance at a fair growth rate. Some factors supporting the growth of this segment are the rapidly evolving healthcare infrastructure in the emerging economies of Asia Pacific, growing healthcare expenditure, and the increasing incidence of lifestyle diseases. The upgrading of existing infrastructure to align with the latest technological developments and the invasion of point-of-care testing also support the growth of this segment. Additionally, the consumables segment will experience the fastest progress in the global market. Large purchase volumes due to greater consumption are mainly attributed to market growth. All the coagulation tests performed require reagents, and therefore a large inventory of the same needs to be maintained. Also, repeat orders of these items are frequent in clinical laboratories. A growing number of tests in developing markets is also expected to spur demand and uptake for consumables.

specialized diagnostic centers to dominate the end-user segment

The rapid expansion in the number of hospitals and healthcare centers is a significant driving factor for the growth of the global hemostasis and coagulation analyzers market. Favorable government steps toward improving the healthcare infrastructure will also direct market growth. Diagnostic centers, followed by hospitals, currently hold the largest market share among end users due to fundamental factors such as higher patient footfall and the lower cost of these facilities in adopting novel diagnostic technologies. Due to the ongoing trend of outsourcing specialized hemostasis tests to diagnostic tests, this segment procures the largest market share on the global front.

Asia Pacific will advance at a rapid pace due to growing awareness and healthcare expenditure.

North America, followed by Europe, is the largest regional market for hemostasis and coagulation analyzers. The region currently occupies over 30% of the global market. Encouraging healthcare policies and the existence of impressive healthcare infrastructure, along with the increasing prevalence of CVDs and hematological conditions, contribute to the dominance of the North American market. Good reimbursements also play a key role in the company’s position in this market. On the basis of a growing patient population and the proliferation of healthcare infrastructure, the Asia Pacific, the Middle East, and Africa will be the fastest-progressing regions. Improving awareness and the growing medical tourism industry in Asian countries also facilitate the progress of this region.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The hemostasis and coagulation analyzers market report provides a quantitative assessment of the industry in terms of current and forecasted market size while also presenting the market dynamics. This market is segmented based on drugs, type of infection, range of action, and geography.

The dynamics in the global hemostasis and coagulation analyzers market are studied for a better understanding of the industry’s progress. Such market dynamics include drivers, challenges, and opportunities, giving insights into the prevalent positive aspects and pain points. Major players in the market are also studied in terms of business overview, financial information, product portfolio, and key developments. The key players operating in the global hemostasis/coagulation analyzers market profiled in this report include Alere Inc. (Abbott Laboratories, Inc.), F-Hoffmann La Roche, Sysmex Corporation, Beckman Coulter, Inc. (Danaher), Nihon Kohden Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare (Siemens AG), International Technidyne Corporation (Werfen), and Beckman Coulter Inc.

Key questions are answered in this report.

• What is the current and forecasted market value of the global hemostasis and coagulation analyzer industry?
• How will the market progress through the forecast period from 2018 to 2016?
• What are the dominant market dynamics, and how significant will their impact be on the market during the forecast period?
• How do the new opportunities facilitate future market growth?
• What are the strategic steps undertaken by the major market players, and what is the current competitive landscape?
• Which region will advance at the fastest rate through the forecast period?
• How will the market’s consumables segment develop?
• What is the current status of Asia Pacific in the global hemostasis and coagulation analyzer market?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global H/CA Market Portraiture
2.2. Global H/CA Market, by Test, 2017 (US$ Mn)
2.3. Global H/CA Market, by Product, 2017 (US$ Mn)
2.4. Global H/CA Market, by End User, 2017 (US$ Mn)
2.5. Global H/CA Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hemostasis/Coagulation Analyzers (H/CA) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global H/CA Market, by Key Players, 2017

Chapter 4. Global Hemostasis/Coagulation Analyzers (H/CA) Market, by Test, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Routine Coagulation Tests
4.2.1. Prothrombin Time (PT)
4.2.2. International Normalized Ratio (INR)
4.2.3. Activated Partial Thromboplastin Time (APTT)
4.2.4. Thrombin Time (TT)
4.2.5. Fibrinogen
4.2.6. D-dimer
4.3. Diagnostic Hemostasis Assays
4.3.1. VWF Assays
4.3.2. Platelet Function Testing
4.3.3. Thrombophilia Testing
4.3.4. Factor Inhibitors
4.3.5. Factor Assays

Chapter 5. Global Hemostasis/Coagulation Analyzers (H/CA) Market, by Product, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Consumables
5.2.1. Reagents
5.2.2. Strips, Standards, Controls, Calibrations, etc.
5.3. Devices
5.3.1. Clinical Laboratory Analyzers
5.3.2. Point of Care Analyzers

Chapter 6. Global Hemostasis/Coagulation Analyzers (H/CA) Market, by End User, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Hospitals & Clinics
6.3. Diagnostic Laboratories
6.4. Clinical laboratories & Research Institutions

Chapter 7. Global Hemostasis/Coagulation Analyzers (H/CA) Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.1.1. North America H/CA Market, 2016-2026 (US$ Mn)
7.1.2. North America H/CA Market, by Test, 2016 – 2026 (US$ Mn)
7.1.3. North America H/CA Market, by Product, 2016 – 2026 (US$ Mn)
7.1.4. North America H/CA Market, by End User, 2016 – 2026 (US$ Mn)
7.1.5. North America H/CA Market, by Country, 2016 – 2026 (US$ Mn)
7.1.5.1. U.S.
7.1.5.2. Canada
7.2. Europe H/CA Market, 2016 – 2026 (US$ Mn)
7.2.1. Europe H/CA Market, by Test, 2016 – 2026 (US$ Mn)
7.2.2. Europe H/CA Market, by Product, 2016 – 2026 (US$ Mn)
7.2.3. Europe H/CA Market, by End User, 2016 – 2026 (US$ Mn)
7.2.4. Europe H/CA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific H/CA Market, 2016 – 2026 (US$ Mn)
7.3.1. Asia Pacific H/CA Market, by Test, 2016 – 2026 (US$ Mn)
7.3.2. Asia Pacific H/CA Market, by Product, 2016 – 2026 (US$ Mn)
7.3.3. Asia Pacific H/CA Market, by End User, 2016 – 2026 (US$ Mn)
7.3.4. Asia Pacific H/CA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America H/CA Market, 2016 – 2026 (US$ Mn)
7.4.1. Latin America H/CA Market, by Test, 2016 – 2026 (US$ Mn)
7.4.2. Latin America H/CA Market, by Product, 2016 – 2026 (US$ Mn)
7.4.3. Latin America H/CA Market, by End User, 2016 – 2026 (US$ Mn)
7.4.4. Latin America H/CA Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa H/CA Market, 2016 – 2026 (US$ Mn)
7.5.1. Middle East & Africa H/CA Market, by Test, 2016 – 2026 (US$ Mn)
7.5.2. Middle East & Africa H/CA Market, by Product, 2016 – 2026 (US$ Mn)
7.5.3. Middle East & Africa H/CA Market, by End User, 2016 – 2026 (US$ Mn)
7.5.4. Middle East & Africa H/CA Market, by Region, 2016 – 2026 (US$ Mn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa

Chapter 8. Company Profiles
8.1. Alere Inc. (Abbott Laboratories, Inc.)
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. F-Hoffmann La Roche
8.3. Sysmex Corporation
8.4. Beckman Coulter, Inc. (Danaher)
8.5. Nihon Kohden Corporation
8.6. Thermo Fisher Scientific Inc.
8.7. Siemens Healthcare (Siemens AG)
8.8. International Technidyne Corporation (Werfen)
8.9. Beckman Coulter Inc.

List of Figures

FIG 1. Hemostasis/Coagulation Analyzers (H/CA) Market: Research Methodology
FIG 2. H/CA Market Segmentation
FIG 3. Global H/CA Market, by Test, 2017 (US$ Mn)
FIG 4. Global H/CA Market, by Product, 2017 (US$ Mn)
FIG 5. Global H/CA Market, by End User, 2017 (US$ Mn)
FIG 6. Global H/CA Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global H/CA Market, by Key Players, 2017
FIG 9. Global Prothrombin Time (PT) Tests Market, 2016-2026(US$ Mn)
FIG 10. Global International Normalized Ratio (INR) Tests Market, 2016-2026 (US$ Mn)
FIG 11. Global Activated Partial Thromboplastin Time (APTT) Tests Market, 2016-2026 (US$ Mn)
FIG 12. Global Thrombin Time (TT) Tests Market, 2016-2026 (US$ Mn)
FIG 13. Global Fibrinogen Tests Market, 2016-2026 (US$ Mn)
FIG 14. Global D-dimer Tests Market, 2016-2026 (US$ Mn)
FIG 15. Global VWF Assays Tests Market, 2016-2026 (US$ Mn)
FIG 16. Global Platelet Function Testing Market, 2016-2026 (US$ Mn)
FIG 17. Global Thrombophilia Testing Market, 2016-2026 (US$ Mn)
FIG 18. Global Factor Inhibitors Tests Market, 2016-2026 (US$ Mn)
FIG 19. Global Factor Assays Tests Market, 2016-2026 (US$ Mn)
FIG 20. Global Hemostasis/Coagulation Test Reagents Market, 2016-2026 (US$ Mn)
FIG 21. Global Hemostasis/Coagulation Test Strips, Standards, Controls, Calibrations, etc. Market, 2016-2026 (US$ Mn)
FIG 22. Global Hemostasis/Coagulation Clinical Laboratory Analyzers Market, 2016-2026 (US$ Mn)
FIG 23. Global Hemostasis/Coagulation Point of Care Analyzers Market, 2016-2026 (US$ Mn)
FIG 24. Global H/CA Market for Hospitals & Clinics, 2016-2026 (US$ Mn)
FIG 25. Global H/CA Market for Diagnostic Laboratories, 2016-2026 (US$ Mn)
FIG 26. Global H/CA Market for Clinical laboratories & Research Institutions, 2016-2026 (US$ Mn)
FIG 27. U.S. H/CA Market, 2016-2026 (US$ Mn)
FIG 28. Canada H/CA Market, 2016-2026 (US$ Mn)
FIG 29. U.K. H/CA Market, 2016-2026 (US$ Mn)
FIG 30. Germany H/CA Market, 2016-2026 (US$ Mn)
FIG 31. Rest of Europe H/CA Market, 2016-2026 (US$ Mn)
FIG 32. China H/CA Market, 2016-2026 (US$ Mn)
FIG 33. Japan H/CA Market, 2016-2026 (US$ Mn)
FIG 34. Rest of Asia Pacific H/CA Market, 2016-2026 (US$ Mn)
FIG 35. Brazil H/CA Market, 2016-2026 (US$ Mn)
FIG 36. Mexico Hemostasis/Coagulation Analyzers
FIG 37. Market, 2016-2026 (US$ Mn)
FIG 38. Rest of Latin America H/CA Market, 2016-2026 (US$ Mn)
FIG 39. GCC H/CA Market, 2016-2026 (US$ Mn)
FIG 40. Rest of Middle East and Africa H/CA Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Hemostasis/Coagulation Analyzers (H/CA) Market Portraiture
TABLE 2 Global H/CA Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 3 Global H/CA Market, by Routine Coagulation Tests, 2016 – 2026 (US$ Mn)
TABLE 4 Global H/CA Market, by Diagnostic Hemostasis Assays, 2016 – 2026 (US$ Mn)
TABLE 5 Global H/CA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 Global H/CA Market, by Consumables, 2016 – 2026 (US$ Mn)
TABLE 7 Global H/CA Market, by Devices, 2016 – 2026 (US$ Mn)
TABLE 8 Global H/CA Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 9 North America H/CA Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 10 North America H/CA Market, by Product, 2016 – 2026 (US$ Mn
TABLE 11 North America H/CA Market, by End User, 2016 – 2026 (US$ Mn
TABLE 12 North America H/CA Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Europe H/CA Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 14 Europe H/CA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Europe H/CA Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 16 Europe H/CA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific H/CA Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific H/CA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific H/CA Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 20 Asia Pacific H/CA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America H/CA Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America H/CA Market, by Product, 2016 – 2026 (US$ Mn
TABLE 23 Latin America H/CA Market, by End User, 2016 – 2026 (US$ Mn
TABLE 24 Latin America H/CA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa H/CA Market, by Test, 2016 – 2026 (US$ Mn)
TABLE 26 Middle East and Africa H/CA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East and Africa H/CA Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 28 Middle East and Africa H/CA Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 29 Alere Inc. (Abbott Laboratories, Inc.): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 F-Hoffmann La Roche: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Beckman Coulter, Inc. (Danaher): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Nihon Kohden Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Thermo Fisher Scientific Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Siemens Healthcare (Siemens AG): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 International Technidyne Corporation (Werfen): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Beckman Coulter Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)